Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 528

    1.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM.

    Diabetes. 2005 Nov;54(11):3140-7.PMID: 16249437 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.

    Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM.

    Diabetes Care. 2007 Jul;30(7):1819-27. Epub 2007 Apr 11.PMID: 17429060 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.

    Kazumi T, Kawaguchi A, Hirano T, Yoshino G.

    Horm Metab Res. 2006 Feb;38(2):119-24.PMID: 16523413 [PubMed - indexed for MEDLINE]Related articles

    6.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

    Kim CH, Park JY, Lee KU, Kim JH, Kim HK.

    Diabetes Metab Res Rev. 2009 Jan;25(1):64-9.PMID: 19065605 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis.

    Dessein PH, Woodiwiss AJ, Joffe BI, Norton GR.

    BMC Cardiovasc Disord. 2007 Oct 29;7:31.PMID: 17967187 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.

    Mainous AG 3rd, Diaz VA, King DE, Everett CJ, Player MS.

    J Am Board Fam Med. 2008 Nov-Dec;21(6):497-503. Erratum in: J Am Board Fam Med. 2009 Mar-Apr;22(2):229. PMID: 18988716 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.

    Hanley AJ, D'Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM; Insluin Resistance Atrherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1263-70.PMID: 11916954 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.

    Stejskal D, Růzicka V, Fanfrdlová G, Kolár V, Bartek J.

    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):93-9.PMID: 16170395 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study.

    Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, Shikata K, Iida M, Kiyohara Y.

    Obesity (Silver Spring). 2007 Jul;15(7):1841-50.PMID: 17636103 [PubMed - indexed for MEDLINE]Related articles

    13.

    Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

    Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

    Diabetes. 2004 Jul;53(7):1773-81.PMID: 15220201 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prediction of coronary atherosclerotic disease with liver transaminase level.

    Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M.

    Liver Int. 2007 Sep;27(7):895-900.PMID: 17696927 [PubMed - indexed for MEDLINE]Related articles

    15.

    Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

    Hepatology. 2008 Sep;48(3):792-8.PMID: 18752331 [PubMed - indexed for MEDLINE]Related articles

    16.

    The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.

    Mykkänen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM.

    Diabetologia. 1999 Sep;42(9):1060-6.PMID: 10447516 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

    André P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschwège E.

    Diabetes Metab. 2005 Dec;31(6):542-50.PMID: 16357802 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.

    Sato KK, Hayashi T, Nakamura Y, Harita N, Yoneda T, Endo G, Kambe H.

    Diabetes Care. 2008 Jun;31(6):1230-6. Epub 2008 Mar 3.PMID: 18316395 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?

    Sargin M, Uygur-Bayramiçli O, Sargin H, Orbay E, Yayla A.

    J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402.PMID: 14564188 [PubMed - indexed for MEDLINE]Related articles

    20.

    Potential role of interleukin-18 in liver disease associated with insulin resistance.

    López-Bermejo A, Bosch M, Recasens M, Biarnés J, Esteve E, Casamitjana R, Vendrell J, Ricart W, Fernández-Real JM.

    Obes Res. 2005 Nov;13(11):1925-31.PMID: 16339124 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data